Unternehmen (1)

IO BIOTECH, INC. 97 Mio $
Logo IO Biotech, Inc.

IO Biotech Inc. ist ein biopharmazeutisches Unternehmen im klinischen Stadium, das immunmodulierende Krebstherapien auf der Grundlage der T-win-Technologieplattform entwickelt. Die Produktkandidaten des Unternehmens sind so konzipiert, dass sie das Immuns ...


Insiders

Foto Ido Wallach
Ido Wallach

Ido Wallach ist Chief Financial Officer der DKSH Holding AG. Zuvor war Herr Wallach als Group Chief Financial Officer bei Keter UK Ltd. tätig. Er erhielt einen MBA von der SDA Bocconi School of Management und einen Bachelor-Abschluss vom University College London.



Foto Russell Wallach
Russell Wallach

Russell Wallach has a career history that includes a current job as a Director at the T.J.
Martell Foundation, which started in 2017.







Foto Ty Edmund Wallach
Ty Edmund Wallach

Mr. Wallach is Chief Investment Officer of Atlas’s credit strategy, having joined in September 2019, and is based in New York.
Previously, Mr. Wallach spent 10 years at Paulson & Co., where he was a Partner and co-portfolio manager of Paulson’s global credit funds.
Prior to joining Paulson in 2008, Mr. Wallach was a Partner at Oak Hill Advisors, serving most recently as Co-Head of European Investments.
He joined Oak Hill in 1994 and co-founded the firm’s London office in 2005.
Mr. Wallach began his career as an investment banker at Kidder, Peabody & Co. He has served on multiple corporate boards.
Originally from Brooklyn, Mr. Wallach grew up in Scarsdale, New York, and earned a Bachelor of Arts degree in the Joint Program in Political Economy from Princeton University.
He serves on the boards of two non-profits, Focus for a Future, Inc. and New Heights Youth, Inc. Mr. Wallach is a CFA Charterholder.


Keine Ergebnisse zu dieser Suche